Register entry
- Registered sites
- 0
- Active NDC listings
- 4
- Live patents
- 8
- Exclusivities
- 1
- Countries
- 0
Catalogue
Drug listings by form and route
44 active NDC listings: 4 human prescription drug. By marketing category: NDA 4.
| Dosage form | NDCs |
|---|---|
| tablet, film coated | 4 |
| Route | NDCs |
|---|---|
| oral | 4 |
| Labeller name on the listing | NDCs |
|---|---|
| cytokinetics inc. | 4 |
Exclusivity
Patents and exclusivities
8| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 10836755 | MYQORZOaficamten | substance, product | Jan 2039 |
| 12370179 | MYQORZOaficamten | use | Jul 2042 |
| Product | Exclusivity | Until |
|---|---|---|
| MYQORZOAFICAMTEN | NCE New chemical entity | Dec 2030 |
Catalogue
Marketed products
4| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| MYQORZO | AFICAMTEN | tablet, film coated, oral | 82112-105NDA |
| MYQORZO | AFICAMTEN | tablet, film coated, oral | 82112-110NDA |
| MYQORZO | AFICAMTEN | tablet, film coated, oral | 82112-115NDA |
| MYQORZO | AFICAMTEN | tablet, film coated, oral | 82112-120NDA |
Enquiry
Common questions
- Is Cytokinetics Inc. FDA approved?
- Cytokinetics Inc. holds no registered establishment of its own; 4 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Cytokinetics Inc. make?
- 4 products are listed under Cytokinetics Inc. in the openFDA NDC Directory, most often as tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.